Healthcare Leads Networking Pharmaceutical manufacturing 
Pharmaceutical Technology
SEPTEMBER 7, 2022
Pharmaceutical and healthcare companies are working continuously to improve patient adherence, which also impacts disease control and pharmaceutical industry revenues directly. Discover the leading patient adherence pharmaceutical companies.
Pharma Marketing Network
JANUARY 18, 2023
Bob is a life sciences and technology marketing leader with more than 25 years of experience working directly for pharmaceutical manufacturers (Merck, AstraZeneca, and Shire) and for technology companies that serve the industry (Appature, IQVIA, and Sparta). The post Bob Harrell appeared first on Pharma Marketing Network.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
European Pharmaceutical Review
OCTOBER 12, 2023
September 2023 saw a wave of new pharmaceutical manufacturing facility expansions and launches across Europe. Research by the Confederation of British Industry (CBI) , released in September this year, highlighted progress for UK manufacturing in its latest Industrial Trends Survey. Meath opened last month.
Pharmaceutical Technology
JULY 28, 2022
After all, around a third of the world’s leading life sciences corporations have their headquarters in the country. Linked to talent, the presence of good universities is another great sign for life sciences, especially institutions with a focus on healthcare. Industry clusters.
Clarify Health
OCTOBER 26, 2021
With the myriad of guidance and recommendations to boost diversity and inclusion in oncology trials, , biotech and pharmaceutical manufacturers are left to interpret the criteria and implement them through tangible action. J National Comprehensive Cancer Network. However, another study found that 0.1% 2] Figure 1.
pharmaphorum
OCTOBER 26, 2022
The status isn’t awarded lightly and Chiesi is the largest pharmaceutical manufacturer to be named a B Corp. “We We start our meetings by bringing to life a patient testimony and asking the team to reflect on how the goal of each meeting ultimately leads back to the needs of patients,” Chiesi says. “If About the author.
European Pharmaceutical Review
JULY 25, 2022
Consequently, pharmaceutical manufacturers risk their reputation if impersonating products fail to deliver the expected quality or health impact. Essentially, both counterfeit and falsified medicines pose risks to public health and threaten to undermine the healthcare system and pharmaceutical industry.
Expert insights. Personalized for you.
52 
Let's personalize your content